Advisors Capital Management LLC lifted its position in shares of AtriCure, Inc. (NASDAQ:ATRC – Free Report) by 25.2% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 57,208 shares of the medical device company’s stock after acquiring an additional 11,529 shares during the […]
AtriCure, Inc. (NASDAQ:ATRC – Get Free Report) was the target of a large drop in short interest during the month of July. As of July 15th, there was short interest totalling 1,030,000 shares, a drop of 9.6% from the June 30th total of 1,140,000 shares. Based on an average daily volume of 284,200 shares, the […]
AtriCure (NASDAQ:ATRC) Updates FY23 Earnings Guidance theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
AtriCure (NASDAQ:ATRC – Get Free Report) had its price objective lifted by equities research analysts at BTIG Research from $56.00 to $68.00 in a research report issued to clients and investors on Wednesday, FlyOnTheWall reports. BTIG Research’s price objective points to a potential upside of 17.79% from the stock’s current price. A number of other […]
AtriCure (NASDAQ:ATRC – Get Free Report) posted its earnings results on Tuesday. The medical device company reported ($0.12) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.27) by $0.15, Briefing.com reports. AtriCure had a negative return on equity of 7.15% and a negative net margin of 7.67%. The company had revenue of […]